Market Overview:
Bronchiectasis is a chronic respiratory condition characterized by the permanent dilation of the bronchi and bronchioles. The market for bronchiectasis drugs is driven by the increasing prevalence of the disease, especially in aging populations. The advantages of bronchiectasis drugs include alleviation of symptoms such as chronic cough, production of excess mucus, and difficulty breathing. These drugs also help in preventing and managing exacerbations ... Read more

Market Overview:
Bronchiectasis is a chronic lung disease characterized by damage to the airways of the lungs which results in a build-up of excess mucus within the lungs. Some of the major symptoms of bronchiectasis include chronic cough, excessive phlegm production, weight loss, fatigue and recurring respiratory infections. Drugs to treat bronchiectasis aim to control or prevent exacerbations, loosen and thin out mucus, treat infections and improve symptoms and lung function. The ... Read more

Bronchiectasis is a chronic lung condition characterized by damaged and widened airways in the lungs. When the walls of the bronchioles or small air passages in the lungs become damaged, it allows pockets of air to get trapped there. This causes inflammation and provides a perfect breeding ground for bacteria. If left untreated, bronchiectasis can cause recurring lung infections and further damage to the lungs over time. While there is no cure for bronchiectasis, various drugs and treatment ... Read more